Clinical Trial Update: Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating autologous adipose tissue–derived mesenchymal stem cell transplantation for degenerative arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Arthritis

Drugs mentioned

• Autologous adipose tissue-derived mesenchymal stem cells (mesenchymal stem cells (autologous adipose tissue-derived))

Snippet

Sponsor: R-Bio | Conditions: Degenerative Arthritis | Phase 1, Phase 2 | Status: COMPLETED